Matthew Biegler
Stock Analyst at Oppenheimer
(3.57)
# 2,200
Out of 4,512 analysts
397
Total ratings
39.5%
Success rate
4.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Biegler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Rated: Hold | n/a | $130.04 | - | 16 | Jun 15, 2026 | |
| CTMX CytomX Therapeutics | Rated: Hold | n/a | $3.66 | - | 12 | Jun 15, 2026 | |
| ARVN Arvinas | Rated: Hold | n/a | $8.27 | - | 17 | Jun 15, 2026 | |
| IDYA IDEAYA Biosciences | Rated: Hold | n/a | $36.65 | - | 20 | Jun 15, 2026 | |
| ORIC ORIC Pharmaceuticals | Rated: Hold | n/a | $10.55 | - | 23 | Jun 15, 2026 | |
| RLAY Relay Therapeutics | Rated: Hold | n/a | $19.08 | - | 18 | Jun 15, 2026 | |
| OLMA Olema Pharmaceuticals | Rated: Hold | n/a | $11.85 | - | 23 | Jun 15, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $7 | $1.85 | +278.38% | 9 | May 14, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $50 | $32.88 | +52.07% | 23 | May 14, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Reiterated: Buy | $9 | $4.77 | +88.68% | 23 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $22.98 | +21.85% | 23 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.29 | +597.67% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.62 | - | 11 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $865 | $656.12 | +31.84% | 13 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $19.24 | +133.89% | 2 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $4.22 | +610.90% | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $8.82 | +149.43% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.59 | +317.83% | 22 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.13 | +275.59% | 13 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.99 | n/a | 32 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.11 | n/a | 5 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 | $18.50 | n/a | 13 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11.24 → $4.21 | $0.365 | n/a | 12 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.46 | n/a | 15 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $0.3331 | n/a | 3 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.755 | n/a | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.65 | n/a | 6 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $50 | $1.44 | n/a | 15 | Feb 17, 2022 |
Gilead Sciences
Jun 15, 2026
Rated: Hold
Price Target: n/a
Current: $130.04
Upside: -
CytomX Therapeutics
Jun 15, 2026
Rated: Hold
Price Target: n/a
Current: $3.66
Upside: -
Arvinas
Jun 15, 2026
Rated: Hold
Price Target: n/a
Current: $8.27
Upside: -
IDEAYA Biosciences
Jun 15, 2026
Rated: Hold
Price Target: n/a
Current: $36.65
Upside: -
ORIC Pharmaceuticals
Jun 15, 2026
Rated: Hold
Price Target: n/a
Current: $10.55
Upside: -
Relay Therapeutics
Jun 15, 2026
Rated: Hold
Price Target: n/a
Current: $19.08
Upside: -
Olema Pharmaceuticals
Jun 15, 2026
Rated: Hold
Price Target: n/a
Current: $11.85
Upside: -
Allogene Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $7
Current: $1.85
Upside: +278.38%
Tyra Biosciences
May 14, 2026
Reiterated: Buy
Price Target: $50
Current: $32.88
Upside: +52.07%
Zentalis Pharmaceuticals
May 13, 2026
Reiterated: Buy
Price Target: $9
Current: $4.77
Upside: +88.68%
May 13, 2026
Reiterated: Buy
Price Target: $28
Current: $22.98
Upside: +21.85%
May 13, 2026
Reiterated: Buy
Price Target: $9
Current: $1.29
Upside: +597.67%
May 12, 2026
Rated: Hold
Price Target: n/a
Current: $8.62
Upside: -
Apr 30, 2026
Reiterated: Buy
Price Target: $865
Current: $656.12
Upside: +31.84%
Mar 27, 2026
Reiterated: Buy
Price Target: $45
Current: $19.24
Upside: +133.89%
Mar 13, 2026
Reiterated: Buy
Price Target: $30
Current: $4.22
Upside: +610.90%
Mar 6, 2026
Reiterated: Buy
Price Target: $22
Current: $8.82
Upside: +149.43%
Dec 8, 2025
Reiterated: Buy
Price Target: $15
Current: $3.59
Upside: +317.83%
Nov 14, 2025
Reiterated: Buy
Price Target: $8
Current: $2.13
Upside: +275.59%
May 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $2.99
Upside: n/a
May 14, 2025
Maintained: Hold
Price Target: n/a
Current: $3.11
Upside: n/a
Dec 9, 2024
Maintained: Buy
Price Target: $160
Current: $18.50
Upside: n/a
Aug 14, 2023
Maintained: Buy
Price Target: $11.24 → $4.21
Current: $0.365
Upside: n/a
Jul 31, 2023
Rated: Hold
Price Target: n/a
Current: $18.46
Upside: n/a
Mar 2, 2023
Maintained: Buy
Price Target: $18
Current: $0.3331
Upside: n/a
Dec 22, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.755
Upside: n/a
Dec 22, 2022
Downgraded: Hold
Price Target: n/a
Current: $2.65
Upside: n/a
Feb 17, 2022
Maintained: Buy
Price Target: $8 → $50
Current: $1.44
Upside: n/a